|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 1/04 | |
| A61P 35/00 | |||
| A61K 31/557 | |||
| C07C 405/00 |
| (11) | Number of the document | 1861169 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06730328.9 |
| Date of filing the European patent application | 2006-03-22 | |
| (97) | Date of publication of the European application | 2007-12-05 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2006/306380 |
| Date | 2006-03-22 |
| (87) | Number | WO 2006/101244 |
| Date | 2006-09-28 |
| (30) | Number | Date | Country code |
| 663200 P | 2005-03-21 | US | |
| 679920 P | 2005-05-11 | US | |
| 721976 P | 2005-09-30 | US |
| (72) |
UENO, Ryuji, US
KUNO, Sachiko, US
BLIKSLAGER, Anthony, T., US
MOESER, Adam, J., US
|
| (73) |
Sucampo AG,
Baarerstrasse 22, 6300 Zug,
CH
NORTH CAROLINA STATE UNIVERSITY, 4700 Hillsborough Street, Raleigh, NC 27606, US |
| (54) | Use of 13,14-dihydro-15-keto-16,16-difluoro prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-18-methyl prostaglandin E1 for the treatment of cancer |
| Use of 13,14-dihydro-15-keto-16,16-difluoro prostaglandin E1 or 13,14-dihydro-15-keto-16,16-difluoro-18-methyl prostaglandin E1 for the treatment of cancer |